Clinical application prospects of Nectin-4 in pan-cancer: an analysis based on the Trialtrove database

Area of Science:

• Oncology
• Molecular Biology
• Clinical Pharmacology

Background:

• Nectin cell adhesion molecule 4 (Nectin-4) is an emerging target in oncology.
• Its role in various malignancies necessitates a comprehensive overview of clinical development.
• Understanding current therapeutic strategies is crucial for advancing cancer treatment.

Purpose of the Study:

• To analyze the global landscape of clinical trials targeting Nectin-4.
• To identify dominant therapeutic modalities and key malignancies under investigation.
• To highlight trends and translational potential in Nectin-4-targeted therapies.

Main Methods:

• Data sourced from the Trialtrove database.
• Analysis encompassed 136 interventional clinical trials.
• Focus on therapies targeting Nectin-4 across diverse cancers.

Main Results:

• The field of Nectin-4-targeted therapies is rapidly expanding globally.
• Antibody-drug conjugates represent the dominant therapeutic modality.
• Urothelial carcinoma shows significant focus, with combination regimens and varied modalities explored.

Conclusions:

• Nectin-4 demonstrates substantial translational potential in oncology.
• Key trends indicate a promising future for Nectin-4-targeted drug development.
• Further exploration of combination therapies and novel modalities is warranted.